Guangxi Wuzhou Pharmaceutical Group

Portfolio · 2

Inovytec Medical Solutions

Emergency Critical Care Devices

1 round $2.0M committed Latest: 2015-01

Oramed Pharmaceuticals

Transforming Injectables into Oral Therapies

1 round $5.0M committed Latest: 2014-11

Investment activity

Q&A

What is Guangxi Wuzhou Pharmaceutical Group's primary investment focus?

Guangxi Wuzhou Pharmaceutical Group primarily invests in the Health Tech & Life Sciences sector, with all of its known portfolio companies falling into this category.

Can you name some of Guangxi Wuzhou Pharmaceutical Group's portfolio companies?

Guangxi Wuzhou Pharmaceutical Group's portfolio includes Inovytec Medical Solutions, which develops emergency critical care devices.

What is the typical investment range for Guangxi Wuzhou Pharmaceutical Group?

Guangxi Wuzhou Pharmaceutical Group typically invests between $2M and $5M per round.

When did Guangxi Wuzhou Pharmaceutical Group make its most recent investments?

Guangxi Wuzhou Pharmaceutical Group made investments in November 2014 and January 2015, according to startupim data.

In which funding stages does Guangxi Wuzhou Pharmaceutical Group typically invest?

Guangxi Wuzhou Pharmaceutical Group has participated in Seed and PIPE funding stages.

What is the status of Oramed Pharmaceuticals, a company in Guangxi Wuzhou Pharmaceutical Group's portfolio?

Oramed Pharmaceuticals is a public company that has raised $149.13M to date.

What is Inovytec Medical Solutions, a company backed by Guangxi Wuzhou Pharmaceutical Group?

Inovytec Medical Solutions, founded in 2011, is a B2B, B2C, and B2G company focused on emergency critical care devices, having raised $8.6M.